4Q24

4Q24

• 4Q24 Earnings Release:

  • Net revenue (ex. foot-and-mouth disease) grew 26.1% in 4Q24 and 14.1% in the accumulated 12M24, reaching R$ 1,017.8 million
  • Growth in Production Animals (ex. foot-and-mouth disease), representing 14.7% compared to 12M23 and 27.8% compared to 4Q23.
  • Growth in Companion Animals, representing 9.2% in 4Q24 and 16.5% in 12M24 compared to the previous year.
  • Strong growth in profitability indicators: Gross margin +7.5 p.p., Adjusted EBITDA Margin +7.4 p.p. and Net margin +7.3 p.p. compared to the previous year.
  • Adjusted EBITDA reaches R$ 221.7 million with 65.0% growth.
  • Leverage at 0.6x EBITDA, with 83.7% of the debt in the long term and an average cost of 7.93% per year at the end of the period